
Severe burn injury induces hepatic ER stress and apoptosis. MCJ (DNAJC15), a mitochondrial complex I repressor, is a therapeutic target in liver injury, but its role post-burn remains unknown. We tested whether hepatocyte-directed GalNAc-siMCJ attenuates post-burn hepatic ER stress and intrinsic apoptosis in young and aged mice. Young and aged female C57BL/6 mice received a 15% TBSA scald burn or sham, followed 1 h later by subcutaneous GalNAc-siMCJ (10 mg/kg) or vehicle. At 48 h, hepatic injury, MCJ, ER stress proteins, Bcl-2 family proteins, fraction-specific cytochrome c, caspase-9, and TUNEL were assessed. Burn increased AST approximately 10- and 6.2-fold, ALT 3.6- and 3.0-fold, and hepatic MCJ ninefold and eightfold in young and aged mice, respectively. ER stress proteins and Bid increased in both age groups, whereas Bak and Bax increased significantly in aged mice. Cytosolic cytochrome c increased in both age groups, mitochondrial cytochrome c decreased by 78% in young mice, and cleaved caspase-9 increased 1.5-fold in aged mice. GalNAc-siMCJ reduced serum aminotransferases, histologic liver injury, MCJ and ER stress-associated proteins, pro-apoptotic Bcl-2 family proteins, TUNEL-positive nuclei by 60% in young and 79% in aged mice, and compartment-specific cytochrome c changes, while increasing Bcl-xL. All stated treatment comparisons were significant at p < 0.05. GalNAc-siMCJ attenuated acute post-burn hepatic injury, ER stress, and intrinsic apoptotic signaling in young and aged mice. These preclinical findings support further evaluation of hepatocyte-directed MCJ silencing after burn injury.
ABSTRACT This study examined NEDD4 expression in tracheobronchial tuberculosis (TBTB) lesions and investigated its function in macrophage polarization in H37Rv whole‐cell lysate (WCL)‐stimulated mouse bone marrow‐derived macrophages (BMDMs). In clinical samples, NEDD4 was downregulated in TBTB lesions and colocalized with the macrophage marker CD68, accompanied by mucosal disruption and inflammatory infiltration. In H37Rv WCL‐stimulated BMDMs, NEDD4 overexpression suppressed M1 markers and pro‐inflammatory cytokines (IL‐6, TNF‐α, IL‐1β, IL‐12), while promoting M2 markers and anti‐inflammatory cytokines (IL‐10, TGF‐β). NEDD4‐overexpressing macrophages also attenuated bronchial epithelial cell damage in a co‐culture system. Conversely, NEDD4 knockdown exerted opposite effects. Mechanistically, NEDD4 enhanced autophagic flux via upregulation of Beclin1 and augmented mitochondrial oxidative phosphorylation (OXPHOS). Pharmacological inhibition of autophagy with 3‐MA or OXPHOS with oligomycin attenuated the NEDD4‐induced M2 polarization. NEDD4 interacted with TLR4 and promoted its ubiquitination and degradation, inhibiting the TRAF6/NF‐κB pathway and upregulating PGC‐1β. TLR4 overexpression abolished NEDD4‐mediated OXPHOS enhancement, which was restored by co‐overexpression of PGC‐1β. Collectively, these findings suggest that in experimental models, NEDD4 promotes M2 polarization through Beclin1‐dependent autophagy and TLR4/TRAF6/NF‐κB/PGC‐1β‐mediated OXPHOS reprogramming, thereby attenuating bronchial epithelial damage. These results identify NEDD4 as a potential candidate for further investigation in TBTB.
ABSTRACT Vascular smooth muscle cell remodeling contributes to neointimal hyperplasia after vascular injury. We examined ferroptosis‐associated transcriptional observations and selected candidate markers in rat carotid injury datasets and tissue specimens. We examined day‐28 single‐cell data (GSE174098), day‐14 bulk data (GSE164050), and day‐14 tissue observations from three paired rats. Reported scores, pathway enrichment, ligand‐receptor inference, exploratory feature rankings, and candidate‐gene expression were reviewed alongside immunohistochemistry and transmission electron microscopy. Retained scripts and the available processed count object were inspected; QC displays were revised without rerunning downstream analyses. The reported single‐cell score was descriptively lower in the injured library, but QC metrics, scoring provenance, and the scored cell subset remain unverified. Bulk enrichment highlighted oxidative‐stress and remodeling pathways. Reported bulk expression and tissue staining showed lower ATG13 and CDO1 and higher PLIN2 in injured arteries. Their independent algorithmic selection is not established. Mitochondrial morphology differed between conditions but did not establish ferroptotic death. These exploratory observations nominate ATG13, CDO1, and PLIN2 as candidate remodeling markers. They do not establish VSMC‐specific gene action, ferroptotic death, or validated therapeutic targets. Small cohorts, different sampling times, and unresolved analytical provenance limit inference and require reanalysis and functional validation.
ABSTRACT The aryl hydrocarbon receptor (AHR) is a ligand‐activated transcription factor implicated in inflammation, immune modulation, and tumor progression. Head and neck squamous cell carcinoma (HNSCC) exhibits elevated AHR expression and basal AHR activity, suggesting that persistent receptor signaling may contribute to tumor behavior. While sustained activation by environmental AHR ligands has been linked to tumor‐promoting phenotypes, the effects of chronic exposure to physiologically relevant endogenous AHR agonists remain poorly defined. Circulating tryptophan (Tryp) metabolites, including kynurenine and indole derivatives, are continuously present in human serum and collectively contribute to basal AHR activity. Here, we examined whether prolonged exposure to a defined mixture of serum‐derived Tryp metabolites promotes aggressive tumor phenotypes in HNSCC. Using a custom dish‐in‐dish culture system to model sustained exposure, we observed persistent AHR activation in HNSCC cells, evidenced by induction of canonical target genes and nuclear AHR translocation. Transcriptomic profiling revealed upregulation of inflammatory and tumor‐associated programs, including CSF3, MMP1, and AP‐1–associated targets. Assay for Transposase‐Accessible Chromatin (ATAC)‐seq analysis demonstrated ligand‐dependent chromatin remodeling and enrichment of inflammatory transcription factor motifs, supporting epigenetic reprogramming during prolonged AHR activation. Sustained Tryp metabolite exposure also enhanced cytokine secretion, proliferation, clonogenic survival, migration, and invasive capacity, many of which were attenuated by pharmacologic AHR antagonism. Together, these findings demonstrate that chronic exposure to endogenous Tryp metabolites drives sustained tumor‐intrinsic AHR signaling and promotes aggressive phenotypes in HNSCC, identifying AHR as a potential contributor to tumor progression and a candidate therapeutic target in HNSCC tumors exhibiting elevated AHR activity.
ABSTRACT Keloids are fibroproliferative skin disorders with limited therapeutic options. Epigenetic regulation, particularly N6‐methyladenosine (m6A) modification, along with inflammatory signaling, is increasingly implicated in their pathogenesis. By analyzing three keloid expression datasets (GSE151464, GSE212954, GSE188952), we identified regulator of G‐protein signaling 1 (RGS1) as a consistently upregulated target. Both RGS1 and the m6A methyltransferase METTL3 were significantly elevated in clinical keloid tissues and primary fibroblasts, showing a positive correlation. MeRIP‐qPCR confirmed abundant m6A modifications on RGS1 mRNA. Silencing METTL3 reduced m6A modification and stability of RGS1 mRNA, whereas RGS1 overexpression did not alter METTL3 levels. In keloid fibroblasts, RGS1 overexpression activated the NF‐κB pathway, enhanced the secretion of IL‐1β, TNF‐α, and IL‐6, elevated reactive oxygen species (ROS), and suppressed antioxidant proteins NQO1 and HO‐1. These effects were reversed by pyrrolidine dithiocarbamate (PDTC), an NF‐κB inhibitor. METTL3 knockdown also impaired fibroblast proliferation, migration, invasion, and reduced fibrosis markers α‐SMA, Vimentin, and COL1, all rescued by RGS1 overexpression. In a xenograft model, RGS1 overexpression accelerated lesion growth and systemic inflammation, which PDTC treatment attenuated. In summary, METTL3‐mediated m6A modification stabilizes RGS1 mRNA, promoting keloid progression through NF‐κB‐dependent inflammation and oxidative stress, highlighting the METTL3/RGS1/NF‐κB axis as a promising therapeutic target.